JPS5932468B2 - Stabilizer for L-ascorbic acid - Google Patents

Stabilizer for L-ascorbic acid

Info

Publication number
JPS5932468B2
JPS5932468B2 JP5911980A JP5911980A JPS5932468B2 JP S5932468 B2 JPS5932468 B2 JP S5932468B2 JP 5911980 A JP5911980 A JP 5911980A JP 5911980 A JP5911980 A JP 5911980A JP S5932468 B2 JPS5932468 B2 JP S5932468B2
Authority
JP
Japan
Prior art keywords
ascorbic acid
acid
solution
stabilizer
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP5911980A
Other languages
Japanese (ja)
Other versions
JPS56156272A (en
Inventor
充朝 津波古
彰夫 田中
秀夫 高原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GOHEIJIMA KAGAKU KOGYO KK
HORIHOSU KAGAKU KENKYUSHO KK
Original Assignee
GOHEIJIMA KAGAKU KOGYO KK
HORIHOSU KAGAKU KENKYUSHO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GOHEIJIMA KAGAKU KOGYO KK, HORIHOSU KAGAKU KENKYUSHO KK filed Critical GOHEIJIMA KAGAKU KOGYO KK
Priority to JP5911980A priority Critical patent/JPS5932468B2/en
Publication of JPS56156272A publication Critical patent/JPS56156272A/en
Publication of JPS5932468B2 publication Critical patent/JPS5932468B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Furan Compounds (AREA)

Description

【発明の詳細な説明】 本発明はL−アスコルビン酸用安定化剤に関する。[Detailed description of the invention] The present invention relates to a stabilizer for L-ascorbic acid.

L−アスコルビン酸即ちビタミンCは、生体に必須なビ
タミンのひとつであり、各種食品及び医薬品に主として
ビタミン強化の目的で、他に酸化防止や鮮度保持剤、食
肉の発色助剤等として広範に使用されている。
L-ascorbic acid, or vitamin C, is one of the essential vitamins for living organisms, and is widely used in various foods and medicines primarily for the purpose of vitamin fortification, as well as as an antioxidant, freshness preservation agent, and coloring aid for meat. has been done.

更に最近該アスコルビン酸が風邪やインフルエンザの予
防、発ガン物質であるN−ニトロソ化合物の生成抑制や
ガンの治療等に効果を示すことが発表され、その有用性
が再検討されつつある。一方上記L−アスコルビン酸は
、空気中や水液中で不安定であり、殊に水溶液中では光
や熱により又は混入する重金属イオンにより極めて速や
かに破壊(酸化分解等)され、本来の有効性が期待でき
ないという致命的欠陥を有している。従来このL−アス
コルビン酸を安定に保存するための各種の安定剤が研究
開発され、そのうち最も優れたもののひとつとしてメタ
リン酸が知られている。しかしながら該メタリン酸は、
一般式(HP03)nで表わされる種々の重合度のリン
酸即ちオルト(P1)、ピロ(P2)、トリ(P3)、
テトラ(P4)、ペンタ(P5)、ヘキサ(P6)、ヘ
プタ(P7)、オクタン(P8)、・・・・・・・・・
長鎖状(Pn)リン酸の混合物であり、本発明者らの研
究によれば之等各リン酸(P1〜Pn)成分の混合比率
が、L−アスコルビン酸安定化効果に重大な影響を与え
ることが判つた。しかるに上記混合比率は、その製造法
は勿論のこと製造条件の若干の変化により大きく変動し
、同一組成の、所望安定化効果を奏し得るメタリン酸を
、常に安定して再現性よく収得することは極めて困難で
ある。このようにメタリン酸はそのアスコルビン酸安定
化効果にばらつきがあると共に、それ自体比較的不安定
で水溶液中で容易に加水分解され、短鎖長のオルト(P
1)リン酸やピロ(P2)リン酸となり、L−アスコル
ビン酸安定化効果がこれにより経時的に低下してしまう
欠点がある。また上記メタリン酸以外の安定化剤として
金属封鎖能の優れた縮合リン酸塩類例えばウルトラリン
酸ナトリウムやヘキサメタリン酸ナトリウム等が提案さ
れているが、之等の安定化効果は、上記メタリン酸より
も尚低く実用上改善すべき余地がある。本発明者らは、
上記現状に鑑み、公知の安定化剤に比しよりー層優れた
L−アスコルビン酸安定化効果を発揮し得、しかもその
効果が製造条件等に係りなく常に一定して安定に発揮さ
れ、更に製品自体食品添加物として許容される安全性を
保証され得る新しい安定化剤を提供することを目的とし
て種々研究を重ねた。
Furthermore, it has recently been announced that ascorbic acid is effective in preventing colds and influenza, inhibiting the production of carcinogenic N-nitroso compounds, and treating cancer, and its usefulness is being reconsidered. On the other hand, the above-mentioned L-ascorbic acid is unstable in air and aqueous liquid, and especially in aqueous solution, it is destroyed extremely quickly (oxidative decomposition, etc.) by light, heat, or mixed heavy metal ions, so that its original effectiveness cannot be improved. It has a fatal flaw that cannot be expected. Conventionally, various stabilizers for stably preserving this L-ascorbic acid have been researched and developed, and metaphosphoric acid is known as one of the most excellent ones. However, the metaphosphoric acid
Phosphoric acids of various degrees of polymerization represented by the general formula (HP03)n, that is, ortho (P1), pyro (P2), tri (P3),
Tetra (P4), Penta (P5), Hexa (P6), Hepta (P7), Octane (P8), etc.
It is a mixture of long-chain (Pn) phosphoric acids, and according to the research of the present inventors, the mixing ratio of each phosphoric acid (P1 to Pn) component has a significant effect on the stabilizing effect of L-ascorbic acid. I found out that I can give it. However, the above-mentioned mixing ratio varies greatly due to slight changes in manufacturing conditions as well as the manufacturing method, and it is difficult to always obtain metaphosphoric acid with the same composition and with good reproducibility that can exhibit the desired stabilizing effect. It is extremely difficult. As described above, metaphosphoric acid has a variable effect on stabilizing ascorbic acid, is itself relatively unstable, is easily hydrolyzed in aqueous solution, and has a short chain length, ortho(P).
1) It has the disadvantage that it becomes phosphoric acid or pyro(P2) phosphoric acid, and the stabilizing effect of L-ascorbic acid decreases over time. In addition, condensed phosphates with excellent metal sequestering ability, such as sodium ultraphosphate and sodium hexametaphosphate, have been proposed as stabilizing agents other than the above-mentioned metaphosphoric acid; It is still low and there is room for practical improvement. The inventors
In view of the above-mentioned current situation, it is possible to exhibit a much superior L-ascorbic acid stabilizing effect compared to known stabilizers, and the effect is always constant and stable regardless of manufacturing conditions, and furthermore, Various studies have been conducted with the aim of providing a new stabilizer that can be guaranteed to be safe enough to be used as a food additive.

その結果金属封鎖能を殆んど発揮し得ない環状トリメタ
リン酸塩が、実に驚くべきことに極めて卓越したL−ア
スコルビン酸安定化作用を発揮し得、上記目的に合致す
る安定化剤となることを見い出した。本発明はこの知見
に基づいて完成されたものである。即ち本発明は、環状
トリメタリン酸塩を有効成分として含有することを特徴
とするL−アスコルビン酸用安定化剤に係る。
As a result, cyclic trimetaphosphate, which exhibits almost no metal sequestering ability, can surprisingly exhibit an extremely excellent stabilizing effect on L-ascorbic acid, becoming a stabilizer that meets the above objectives. I found out. The present invention was completed based on this knowledge. That is, the present invention relates to a stabilizer for L-ascorbic acid characterized by containing a cyclic trimetaphosphate as an active ingredient.

本発明安定化剤は、従来公知のこの種安定化剤には見ら
れない極めて優れたL−アスコルビン酸安定化作用を常
に安定して、しかもL−アスコルビン酸が最も分解され
やすい高温下及び重金属イオンの存在下においても発揮
し得る点において特徴付けられる。
The stabilizer of the present invention has an extremely excellent stabilizing effect on L-ascorbic acid, which has not been found in conventional stabilizers of this kind, and can be used stably at high temperatures and under heavy metals, where L-ascorbic acid is most likely to be decomposed. It is characterized by its ability to exhibit its properties even in the presence of ions.

本発明の安定化剤が斯かる優れた効果を奏し得る理由は
、現在明確ではないが、有効成分とする環状トリメタリ
ン酸塩は、他のリン酸塩とは異なり通常L−アスコルビ
ン酸が含有される食品等の示す酸性条件下では、容易に
開環して非常に活性なラジカルの状態となる所から、こ
れがL−アスコルビン酸と何らかのかたちで反応して該
アスコルビン酸を安定な状態に保持するためと考えられ
る。いずれにせよ上記環状トリメタリン酸塩は、従来こ
の種安定化剤として提案されている縮合リン酸塩に見ら
れる如き金属イオン封鎖作用(マスキング作用)を殆ん
ど有しておらず、従つて之等公知の安定化剤からは全く
予期できない別異の作用機構によりL−アスコルビン酸
を安定化させるものと考えられる。本発明安定化剤の有
効成分とする環状トリメタリン酸塩としては、代表的に
は環状トリメタリン酸ナトリウム(Na3P3O9)を
例示できる。
The reason why the stabilizer of the present invention can exhibit such excellent effects is currently not clear, but unlike other phosphates, cyclic trimetaphosphate, which is an active ingredient, usually contains L-ascorbic acid. Under acidic conditions such as those found in food products, L-ascorbic acid easily opens its ring and becomes a highly active radical, which reacts with L-ascorbic acid in some way to maintain the ascorbic acid in a stable state. It is thought that this is because of this. In any case, the above-mentioned cyclic trimetaphosphate has almost no metal ion sequestration effect (masking effect) as seen in condensed phosphates that have been proposed as this type of stabilizer, and therefore It is thought that L-ascorbic acid is stabilized by a completely different mechanism of action that cannot be expected from known stabilizers such as L-ascorbic acid. A typical example of the cyclic trimetaphosphate used as an active ingredient in the stabilizer of the present invention is cyclic sodium trimetaphosphate (Na3P3O9).

該化合物には三つの形態即ちI型(Na3P3O,−1
)、型及び型があり、本発明では之等のいずれの形態の
ものも同様に有効に使用できる。また上記Na3p3O
9で表わされる無水物は、これを水に溶解後再結晶させ
ることにより1、1.5、3及び6水和物等の各種水和
物結晶とすることができる。例えば上記Na3p3O9
のI型、型又は型を約60〜70℃に保温した蒸留水中
に溶解し飽和溶液を作成後沢過し、沢液に少量のアルコ
ールを加え冷蔵庫(約10℃以下)中で一夜放置するこ
とによつて、X線分析の結果Na3p3O,・6H20
と認められる白色結晶が収得できる。之等の水和物も亦
本発明所期の安定化作用を発揮し得、同様に有利に使用
できる。更に本発明の有効成分化合物には、上記環状ト
リメタリン酸のナトリウム塩の他に、カリウム塩等の他
のアルカリ金属塩も包含される。上記有効成分化合物は
各種方法に従い容易に製造することができる。代表的製
造法を上記Na3p3O9につき例示すれば次の通りで
ある。即ちリン酸一ナトリウム(NaH2PO4・2H
20、結晶)を磁製の蒸発皿又はルツボに入れ、約50
0〜530℃で約3時間加熱し、それをゆつくり徐冷し
たのち粉砕することにより白色粉末として収得できる。
尚加熱時間は、使用するリン酸一ナトリウムの量によつ
て異なり、また加熱時の雰囲気(水蒸気圧)によつて生
成するNa3p3O9の収量は、若干変化するが、通常
の加熱雰囲気下ではほとんど変化は認められない。また
上記Na3p3O9は、例えばNaH2PO4やヘキサ
メタリン酸ナトリウム、長鎖状リン酸ナトリウム等のリ
ン酸塩を白金ルツボに人れ、弱い炎の上でまずゆつくり
溶融し、次いでこの溶融物を更に約1000℃の電気炉
中で約3〜5時間溶融を続けた後、非常にゆつくりと冷
却する(通常約20時間を要して約50℃まで降温する
)ことによつてもI型として収得できる。上記の場合冷
却速度が速いと無定形の不溶性長鎖状縮合リン酸塩が生
成し、目的とするNa3p3O9は収得し難い。上記の
如くしてNa3p3O9が単一化合物として収得できる
ことは、X線分析により確認される。また本発明に用い
る環状トリメタリン酸塩は、いずれも水に可溶であり、
Na3P3O9(無水物)は、融点627.6℃、密度
(d)2.476、屈折率(n)1.478、溶解度2
17/水1007の性質を示す。本発明のL−アスコル
ビン酸用安定化剤は、基本的には、上記環状トリメタリ
ン酸塩を単独で又はこれに必要に応じて適当な添加剤を
配合して、粉末状もしくは水溶液状形態とされる。
The compound has three forms namely type I (Na3P3O, -1
), types, and molds, and any of these forms can be equally effectively used in the present invention. In addition, the above Na3p3O
The anhydride represented by 9 can be dissolved in water and then recrystallized to form various hydrate crystals such as 1, 1.5, 3 and hexahydrates. For example, the above Na3p3O9
Form I, type or mold is dissolved in distilled water kept at about 60-70°C to make a saturated solution, filtered, and a small amount of alcohol is added to the distilled solution and left overnight in the refrigerator (below about 10°C). In particular, as a result of X-ray analysis, Na3p3O,.6H20
A white crystal that can be obtained can be obtained. These hydrates can also exhibit the stabilizing effect desired by the present invention, and can be used advantageously as well. Furthermore, the active ingredient compounds of the present invention include other alkali metal salts such as potassium salts in addition to the above-mentioned sodium salts of cyclic trimetaphosphoric acid. The above active ingredient compounds can be easily produced according to various methods. A typical manufacturing method for the above Na3p3O9 is as follows. That is, monosodium phosphate (NaH2PO4.2H
20, crystal) in a porcelain evaporating dish or crucible, about 50
It can be obtained as a white powder by heating at 0 to 530°C for about 3 hours, slowly cooling it, and then pulverizing it.
The heating time will vary depending on the amount of monosodium phosphate used, and the yield of Na3p3O9 will vary slightly depending on the atmosphere during heating (water vapor pressure), but under normal heating atmosphere there will be almost no change. It is not allowed. The above-mentioned Na3p3O9 can be obtained by pouring a phosphate such as NaH2PO4, sodium hexametaphosphate, or long-chain sodium phosphate into a platinum crucible, slowly melting it over a weak flame, and then heating the melt to about 1000°C. Form I can also be obtained by continuing melting in an electric furnace for about 3 to 5 hours and then cooling very slowly (usually taking about 20 hours to lower the temperature to about 50°C). In the above case, if the cooling rate is fast, an amorphous insoluble long-chain condensed phosphate is produced, making it difficult to obtain the target Na3p3O9. The fact that Na3p3O9 can be obtained as a single compound as described above is confirmed by X-ray analysis. Further, all of the cyclic trimetaphosphates used in the present invention are soluble in water,
Na3P3O9 (anhydride) has a melting point of 627.6°C, a density (d) of 2.476, a refractive index (n) of 1.478, and a solubility of 2.
17/Water 1007 properties are shown. The stabilizer for L-ascorbic acid of the present invention is basically prepared by using the above-mentioned cyclic trimetaphosphate alone or by blending it with appropriate additives as necessary in the form of a powder or an aqueous solution. Ru.

上記必要に応じ添加され得る添加剤としては、トリポリ
リン酸塩、ピロリン酸塩、ヘキサリン酸塩、ウルトラリ
ン酸塩等の縮合リン酸塩及びオルトリン酸塩や、クエン
酸、酒石酸、リンゴ酸等の有機酸又はその塩等を例示で
きる。本発明安定化剤は、その使用に当つてはこれをL
−アスコルビン酸自体又は該アスコルビン酸を含有する
製品例えば果実ジユーズ、果実缶詰等の食品や医薬品等
に添加混合すればよい。
The additives that may be added as necessary include condensed phosphates and orthophosphates such as tripolyphosphate, pyrophosphate, hexaphosphate, and ultraphosphate, and organic acids such as citric acid, tartaric acid, and malic acid. Examples include acids and salts thereof. When using the stabilizer of the present invention, it is necessary to
- It may be added and mixed to ascorbic acid itself or products containing the ascorbic acid, such as foods such as fruit juices and canned fruits, medicines, etc.

安定化剤の使用量は、これを添加混合すべき製品の種類
等に応じて適宜に決定できるが、通常果実ジユーズ等で
は、L−アスコルビン酸が0.1%程度まで即ち1f/
l程度配合されており、これに対して有効成分化合物を
リン乃の濃度に換算して約0.08〜107/f!の範
囲とするのが好ましい。かくして本発明安定化剤により
安定化されたLアスコルビン酸は、その本来のビタミン
強化等の作用を長期に亘り保持しており、従つてその通
常の用途即ち果実類のジユーズ、果実缶詰、ジヤム、ド
ロツプ、粉末ジユーズ等の菓子類、乳製品、清涼飲料水
、ビール、マーカリン等や医薬品等に極めて有効に利用
できると共に、従来L−アスコルビン酸の使用が不適当
であつた加熱等を受ける食品等に対しても利用可能とな
る。以下本発明安定化剤の効果を明らかとするための実
験例を掲げる。
The amount of stabilizer to be used can be determined as appropriate depending on the type of product to which it is added and mixed, but usually in fruit juices, L-ascorbic acid is up to about 0.1%, that is, 1f/
The active ingredient compound is about 0.08 to 107/f in terms of concentration of phosphorus! It is preferable to set it as the range of. In this way, the L-ascorbic acid stabilized by the stabilizer of the present invention retains its original vitamin-enhancing effects over a long period of time, and is therefore suitable for its usual uses, such as fruit juices, canned fruits, jams, etc. It can be used extremely effectively in confectionery such as drops and powdered juices, dairy products, soft drinks, beer, marcarin, etc., and pharmaceuticals, as well as foods that are subject to heating, etc., for which the use of L-ascorbic acid was traditionally inappropriate. It will also be available for use. Experimental examples for clarifying the effects of the stabilizer of the present invention are listed below.

実験例 1 目本薬局方(第9改正)に準じて以下の通りアスコルビ
ン酸の定量を行ない、その水溶液の経時的安定性試験を
行なつた。
Experimental Example 1 Ascorbic acid was determined as follows in accordance with the Japanese Pharmacopoeia (9th edition), and the stability test over time of the aqueous solution was conducted.

(1)アスコルビン酸 市販の特級L−アスコルビン酸を使用する。(1) Ascorbic acid Commercially available special grade L-ascorbic acid is used.

(2)滴定用2・6−ジクロルフエノールインドフエノ
ールナトリウム試薬の調製NaHCO3O.O42yに
水50m1を加えて溶かし、更に2・6−ジクロルフエ
ノールインドフエノールナトリウム0.057を溶かし
、水を加えて全量200m1とし、▲過する。
(2) Preparation of 2,6-dichlorophenol indophenol sodium reagent for titration NaHCO3O. Add 50 ml of water to O42y and dissolve, further dissolve 0.057 ml of 2,6-dichlorophenol indophenol sodium, add water to make a total volume of 200 ml, and filter.

用時調製する。(3)標定 アスコルビン酸標準品をシリカゲルデシケータ一で、2
4時間乾燥し、その約0.05yを精密に量り、メタリ
ン酸・酢酸試液を加えて溶かし、正確に100m1とし
、その2dを正確に量り、メタリン酸・酢酸試液8T1
1を加えて振り混ぜ、滴定用2・6−ジクロルフエノー
ルイン下フエノールナトリウム試薬で5秒間持続する淡
紅色を呈するまで滴定する。
Prepare immediately before use. (3) Standardized ascorbic acid standard product in a silica gel desiccator,
Dry for 4 hours, then accurately weigh out about 0.05y, add metaphosphoric acid/acetic acid test solution and dissolve it to make exactly 100ml, then accurately weigh out 2d, and add metaphosphoric acid/acetic acid test solution 8T1.
1, shake, and titrate with phenol sodium reagent under 2,6-dichlorophenol for titration until it exhibits a pale pink color that lasts for 5 seconds.

同様に空試験をし、上記滴定値を補正し、この試薬1m
1に対するL−アスコルビン酸(C6H8O6)の量A
7rl9を計算する。本実験に用いた2・6−ジクロル
フエノールインドフエノールナトリウム試薬1m1は、
0.1ηC6H8O6であつた。
Perform a blank test in the same way, correct the above titration value, and use 1 m of this reagent.
Amount A of L-ascorbic acid (C6H8O6) per 1
Calculate 7rl9. 1 ml of 2,6-dichlorophenol indophenol sodium reagent used in this experiment was
It was 0.1ηC6H8O6.

)メタリン酸・酢酸試液の調製 メタリン酸157及び氷酢酸40m1に水を加えて溶か
し500m1とする。
) Preparation of metaphosphoric acid/acetic acid test solution Add water to 157 metaphosphoric acid and 40 ml of glacial acetic acid and dissolve to make 500 ml.

冷所に保存する。試液は調製2日以内に使用する。この
試液中のリン濃度は、下記(6)記載の比色分析の結果
Pとして4.7t/500WLIである。))供試液の
調製 市販特級L−アスコルビン酸の0.25〜0.57を正
確に秤取し、これを下記各種リン酸塩の水溶液又はメタ
リン酸・酢酸溶液に加えて溶かし、更に蒸留水を加え、
全量を500m1とする。
Store in a cool place. Use the test solution within 2 days of preparation. The phosphorus concentration in this test solution is 4.7t/500WLI as the result P of the colorimetric analysis described in (6) below. )) Preparation of test solution Accurately weigh 0.25 to 0.57 of commercially available special grade L-ascorbic acid, add it to the following aqueous solutions of phosphates or metaphosphoric acid/acetic acid solutions, dissolve, and add distilled water. Add
The total volume is 500ml.

尚各供試液中のリン濃度(P)は4.77/500m1
と一定にする。対照として蒸留水にL−アスコルビン酸
を溶かした液を作成する。く供試液〉 (T)環状トリメタリン酸ナトリウム (Na3P3O9、本発明品)添加液 後記製造例1で得たNa3p3O9を使用。
The phosphorus concentration (P) in each sample solution is 4.77/500ml
and keep it constant. As a control, a solution of L-ascorbic acid dissolved in distilled water was prepared. Test solution> (T) Additive solution of cyclic sodium trimetaphosphate (Na3P3O9, product of the present invention) Na3p3O9 obtained in Production Example 1 described later was used.

([[)環状テトラメタリン酸ナトリウム(Na4P4
Ol2)添加液 五酸化二リン(P2O5)507を300111の氷水
中で加水分解し、この加水分解生成物を濃苛性ソーダ溶
液を用いてPH7まで中和後、これに少量のエタノール
を加えることにより析出するNa4p4Ol2・4H2
0結晶を使用。
([[) Cyclic sodium tetrametaphosphate (Na4P4
OL2) Additive solution Hydrolyze diphosphorus pentoxide (P2O5) 507 in 300111 ice water, neutralize this hydrolysis product to pH 7 using concentrated caustic soda solution, and precipitate by adding a small amount of ethanol to this. Na4p4Ol2・4H2
Uses 0 crystals.

匝 ウルトラリン酸ナトリウム添加液食品添加物「ウル
トラポリス」(御幣島化学工業(株)社製、白色粉末、
1%溶液のPHl.7〜1.9、P2O5含量76〜8
0%)を使用。
Ultra Sodium Phosphate Additive Liquid Food additive "Ultrapolis" (manufactured by Mihejima Chemical Industry Co., Ltd., white powder,
PHL of 1% solution. 7-1.9, P2O5 content 76-8
0%) is used.

(IV)ヘキサメタリン酸ナトリウム(グラハム塩)添
加液食品添加物「メタリン酸ナトリウム」(同土社製、
白色粉末、1%溶液のPH642〜6.8、P2O5含
量66〜70%)を使用。
(IV) Sodium hexametaphosphate (Graham salt) additive liquid Food additive "Sodium metaphosphate" (manufactured by Dodosha,
White powder, 1% solution pH 642-6.8, P2O5 content 66-70%) was used.

V トリポリリン酸ナトリウム(Na5P3OlO)添
加液食品添加物「ポリリン酸ナトリウム」(燐化学工業
(株)社製、白色粉末、1%溶液のPH9.2〜9.8
、P2O5含量56〜58%)を使用。
V Sodium tripolyphosphate (Na5P3OlO) additive liquid Food additive "sodium polyphosphate" (manufactured by Rin Kagaku Kogyo Co., Ltd., white powder, 1% solution, pH 9.2-9.8
, P2O5 content 56-58%).

(V[)リン酸一水素ナトリウム(Na2HPO4・1
2H20)添加液 食品添加物「リン酸二ナトリウム(結晶)」(御幣島化
学工業(株)社製、無色乃至白色結晶、1%溶液のPH
9.O〜9.4、純分98.0〜100%)を使用。
(V[) Sodium monohydrogen phosphate (Na2HPO4・1
2H20) Additive liquid food additive "disodium phosphate (crystal)" (manufactured by Miheijima Chemical Industry Co., Ltd., colorless to white crystal, PH of 1% solution
9. 0~9.4, purity 98.0~100%).

(MI)酸性ピロリン酸ナトリウム (Na2H2P2O7)添加液 食品添加物「酸性ピロリン酸ナトリウム」(燐化学工業
(株)社製、白色結晶性粉末、1%溶液のPH4.5〜
5.0、P2O5含量60〜65%)を使用。
(MI) Sodium acid pyrophosphate (Na2H2P2O7) additive liquid Food additive "Sodium acid pyrophosphate" (manufactured by Rin Kagaku Kogyo Co., Ltd., white crystalline powder, 1% solution pH 4.5 ~
5.0, P2O5 content 60-65%).

()メタリン酸・酢酸溶液 上記(4)で調製したメタリン酸・酢酸試液と同一の溶
液を用いる。
() Metaphosphoric acid/acetic acid solution Use the same solution as the metaphosphoric acid/acetic acid test solution prepared in (4) above.

へ対照液(蒸留水使用) (6) リンの定量 リンモリブデンブルーによる吸光光度法を用いる。Control solution (using distilled water) (6) Determination of phosphorus Absorption photometry with phosphomolybdenum blue is used.

使用したモリブデン試液は、特級モリブデン酸アンモニ
ウム〔(NH4)6M07024・4H20〕357を
200111の蒸留水に溶かし、それに濃塩酸200m
1を加えていくと、最初白色沈殿が生成するが、次第に
溶解する。これに金属亜鉛3yを加え、次いでよく攪拌
しながら濃塩酸200m1及び予め氷冷した濃硫酸40
0m1を加え蒸留水で全量1000m1とする。かくし
て得られる試液はきれいな青緑色溶液である。この試液
2m1をリンを含む試料溶液に加え、さらに蒸留水約5
m1を加え、よく撹拌後95℃のΔ浴中で1時間加熱し
、冷却後蒸留水で全量を25m1とする。吸光度は83
0nmの波長を用いて日立分光光度計100−20形を
用い測定した。(7) L−アスコルビン酸安定性試験
上記(5)により調製した各供試液を室温下に放置し、
試液調製より所定日数経過後に各液2m1宛を取り、上
記(3)に準じて、そのL−アスコルビン酸残存量(t
)を求め、当初のL−アスコルビン酸量(′Ii)に対
する百分率にて、L−アスコルビン酸の経時的安定性を
調べる。
The molybdenum test solution used was prepared by dissolving special grade ammonium molybdate [(NH4)6M07024.4H20] 357 in 200111 distilled water, and adding 200ml of concentrated hydrochloric acid to it.
As 1 is added, a white precipitate initially forms, but gradually dissolves. Add 3y of metallic zinc to this, and then, while stirring well, add 200ml of concentrated hydrochloric acid and 40ml of concentrated sulfuric acid cooled in advance on ice.
Add 0ml and make the total volume to 1000ml with distilled water. The test solution thus obtained is a clear blue-green solution. Add 2 ml of this test solution to the sample solution containing phosphorus, and add about 5 ml of distilled water.
After stirring thoroughly, the mixture was heated in a 95°C delta bath for 1 hour, and after cooling, the total volume was made up to 25 ml with distilled water. Absorbance is 83
Measurement was performed using a Hitachi spectrophotometer model 100-20 using a wavelength of 0 nm. (7) L-ascorbic acid stability test Each test solution prepared according to (5) above was left at room temperature,
After a predetermined number of days have elapsed since the test solution preparation, take 2 ml of each solution and measure the residual amount of L-ascorbic acid (t) according to (3) above.
) is determined, and the stability of L-ascorbic acid over time is examined as a percentage of the initial amount of L-ascorbic acid ('Ii).

結果を第1図に示す。第1図中縦軸は、L−アスコルビ
ン酸残存率(%)を、横軸は、経過日数(日)を示す。
The results are shown in Figure 1. In FIG. 1, the vertical axis shows the L-ascorbic acid residual rate (%), and the horizontal axis shows the number of elapsed days (days).

図中1〜は、上記(6)記載の各供試液(1)〜(ホ)
に対応する。第1図より明らかな通り本発明の安定化剤
を使用した液(供試液1)では、28日(4週間)経過
後においても、L−アスコルビン酸残存率が約80%を
保持しており、該安定化剤がLアスコルビン酸の安定性
を顕著に向上させることが判る。
1 to 1 in the figure represent each sample solution (1) to (e) described in (6) above.
corresponds to As is clear from Figure 1, in the solution using the stabilizer of the present invention (test solution 1), the L-ascorbic acid residual rate remained at approximately 80% even after 28 days (4 weeks). , it can be seen that the stabilizer significantly improves the stability of L-ascorbic acid.

これに対し従来最も優れたものとして知られるメタリン
酸を用いた液(供試液)では、28日経過後約60%の
残存率にとどまり、ウルトラリン酸塩使用(供試液)や
ヘキサメタリン酸塩使用(供試液)では、同28日経過
後の残存率は50%にも満たないことが判る。次いで上
記各供試液及び他の各種市販のリン酸塩を用X.伺様に
作成した液(いずれもリン濃度P−4.77/500m
1)を、同一試験に供し、21日(3週間)経過後のア
スコルビン酸残存率(%)を同様に求めた結果を下記第
1表に示す。
On the other hand, the solution using metaphosphoric acid (test solution), which is known as the best so far, only had a residual rate of about 60% after 28 days, and the residual rate was only about 60% after 28 days. It can be seen that the residual rate of the sample solution after 28 days was less than 50%. Next, using each of the above test solutions and various other commercially available phosphates, X. The solution prepared by Mr. Ishikawa (both have a phosphorus concentration of P-4.77/500m)
1) was subjected to the same test, and the ascorbic acid residual rate (%) after 21 days (3 weeks) was determined in the same manner. The results are shown in Table 1 below.

上記第1表からも本発明安定化剤が他のリン酸塩及びリ
ン酸とは異なつて卓越したL−アスコルビン酸安定化効
果を奏し得ることが明白である。
It is clear from Table 1 above that the stabilizer of the present invention can exhibit an excellent stabilizing effect on L-ascorbic acid, unlike other phosphates and phosphoric acid.

実験例 2 実験例1において各供試液を作成後70℃の高温条件下
に放置する以外は同様にした。
Experimental Example 2 The same procedure as in Experimental Example 1 was carried out except that each test solution was left under a high temperature condition of 70° C. after preparation.

結果を第2図に示す。第2図より明らかな通り、環状ト
リメタリン酸ナトリウムを用いた本発明安定化剤は、メ
タリン酸に比し、高温下においてもL−アスコルビン酸
安定化効果が大きいことが判る。
The results are shown in Figure 2. As is clear from FIG. 2, the stabilizer of the present invention using cyclic sodium trimetaphosphate has a greater stabilizing effect on L-ascorbic acid even at high temperatures than metaphosphoric acid.

実験例 3 実験例1において各供試液中にSn2+イオン100p
pmを存在させ、同様の試験を行なつた。
Experimental Example 3 In Experimental Example 1, 100p of Sn2+ ions were added to each sample solution.
A similar test was conducted in the presence of pm.

結果を第3図に示す。第3図よりSn2+イオンの存在
により蒸留水ではアスコルビン酸は、速やかに分解され
るのに対し、本発明安定化剤を用いると、上記分解が極
めて抑制され、安定性が顕著に向上することが判る。
The results are shown in Figure 3. Figure 3 shows that ascorbic acid is rapidly decomposed in distilled water due to the presence of Sn2+ ions, but when the stabilizer of the present invention is used, the above decomposition is extremely suppressed and the stability is significantly improved. I understand.

かかる効果は、メタリン酸や酸性ピロリン酸ナトリウム
では期待できない。以下本発明安定化剤の有効成分化合
物である環状トリメタリン酸塩の製造例を挙げる。
Such an effect cannot be expected with metaphosphoric acid or sodium acid pyrophosphate. Examples of the production of cyclic trimetaphosphate, which is the active ingredient compound of the stabilizer of the present invention, will be given below.

製造例 1 無水リン酸一ナトリウム(試薬特級)10007をルツ
ボ(蒸発皿)に秤り、電気炉中で温度530±5℃(水
銀温度計)で3時間加熱する。
Production Example 1 Anhydrous monosodium phosphate (special grade reagent) 10007 is weighed in a crucible (evaporating dish) and heated in an electric furnace at a temperature of 530±5°C (mercury thermometer) for 3 hours.

それをゆつくり徐冷した後粉砕して環状トリメタリン酸
ナトリウム(Na3P3O9)9007を得る。得られ
たNa3p3O9はX線分析よりI型の結晶構造を有す
ることが判る。そのX線回折図を第4図に示す。図中縦
軸はX線回折強度を、横軸は回折角度(2θ)を示す。
尚該図の測定条件は次の通りである。製造例 2 上記製造例1で製造したNa3P3O9(I型)の白色
粉末90yを、約60℃に加温した蒸留水500m1に
添加し溶解後、沢過して不溶解残分を除去し、沢液を1
0℃以下に冷却し、これにエタノール200m1を少量
づつ添加し結晶を析出させ、これを吸収ろ過する。
It is slowly cooled and then crushed to obtain cyclic sodium trimetaphosphate (Na3P3O9) 9007. X-ray analysis shows that the obtained Na3p3O9 has a type I crystal structure. The X-ray diffraction diagram is shown in FIG. In the figure, the vertical axis shows the X-ray diffraction intensity, and the horizontal axis shows the diffraction angle (2θ).
The measurement conditions in this figure are as follows. Production Example 2 90y of the white powder of Na3P3O9 (Type I) produced in Production Example 1 above was added to 500ml of distilled water heated to about 60°C, dissolved, and filtered to remove undissolved residue. 1 liquid
Cool to below 0°C, add 200 ml of ethanol little by little to precipitate crystals, and filter by absorption.

かくして得られる白色結晶は、上記製造例1と同様のX
線分析の結果、第5図に示すX線回折図を与え、この図
よりNa3p3O9・6H20であることが認識された
。
The white crystals thus obtained were prepared using the same X as in Production Example 1 above.
As a result of the ray analysis, the X-ray diffraction diagram shown in FIG. 5 was obtained, and it was recognized from this diagram that it was Na3p3O9.6H20.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図乃至第3図は、各種溶液中でのL−アスコルビン
酸残存率(%)の経時的変化を示すグラフであり、第1
図は室温下、第2図は70℃の温度条件下及び第3図は
Sn2+イオン共存下における結果を夫々示す。
Figures 1 to 3 are graphs showing changes over time in the residual rate (%) of L-ascorbic acid in various solutions.
The figure shows the results under room temperature, FIG. 2 shows the results under a temperature condition of 70° C., and FIG. 3 shows the results under the coexistence of Sn2+ ions.

Claims (1)

【特許請求の範囲】[Claims] 1 環状トリメタリン酸塩を有効成分として含有するこ
とを特徴とするL−アスコルビン酸用安定化剤。
1. A stabilizer for L-ascorbic acid, characterized by containing cyclic trimetaphosphate as an active ingredient.
JP5911980A 1980-05-02 1980-05-02 Stabilizer for L-ascorbic acid Expired JPS5932468B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5911980A JPS5932468B2 (en) 1980-05-02 1980-05-02 Stabilizer for L-ascorbic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5911980A JPS5932468B2 (en) 1980-05-02 1980-05-02 Stabilizer for L-ascorbic acid

Publications (2)

Publication Number Publication Date
JPS56156272A JPS56156272A (en) 1981-12-02
JPS5932468B2 true JPS5932468B2 (en) 1984-08-09

Family

ID=13104098

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5911980A Expired JPS5932468B2 (en) 1980-05-02 1980-05-02 Stabilizer for L-ascorbic acid

Country Status (1)

Country Link
JP (1) JPS5932468B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6239684A (en) * 1985-08-12 1987-02-20 House Food Ind Co Ltd Anti-oxidizing composition
JP2604828B2 (en) * 1987-10-15 1997-04-30 武田薬品工業株式会社 Method for producing stable sodium ascorbate powder
JP2604829B2 (en) * 1987-10-19 1997-04-30 武田薬品工業株式会社 Method for producing stable ascorbic acid composition and powder

Also Published As

Publication number Publication date
JPS56156272A (en) 1981-12-02

Similar Documents

Publication Publication Date Title
Stadtman [39] Preparation and assay of acetyl phosphate
US5908647A (en) Mineral powders with enhanced chromium solubility and preparation methods therefor
US2783132A (en) Stabilization of hydrogen peroxide
Anderson The hydrolysis of phytin by the enzyme phytase contained in wheat bran
Salutsky et al. Properties of fertilizer materials, metal potassium phosphates
US2135054A (en) Treatment of milk and milk preparations
US3656890A (en) Chlorinated trisodium phosphates
US3272588A (en) Method of inhibiting corrosion with slowly soluble phosphate glasses
US2481807A (en) Method of producing monofluorophosphates
CA1295804C (en) Alkali metal acid pyrophosphate leavening acid compositions and methods for producing the same
Shen et al. Hydrolytic degradation of sodium tripolyphosphate in concentrated solutions and in presence of foreign ions
Ohashi et al. Condensed Vanadate-Phosphates
Delphin et al. Designed syntheses of tri-. mu.-chlorohexachlorodimolybdate (3-) anion and the new tri-. mu.-chlorohexachlorodimolybdate (2-) anion
US2927861A (en) Food compositions
CN106977552B (en) The preparation method of citric acid ferric pyrophosphate mixed air EDM
US2365438A (en) Mineral supplement
US3401046A (en) Method of making a composition useful in meat curing
Lecher et al. The phosphonation of aromatic compounds with phosphoric anhydride1
CN100999451B (en) Preparation method of cypressol metal compound
CN1313833A (en) Preparation method of sodium trisodium pyrophosphate
JPH04927B2 (en)
Briggs A Stable Metaphosphate Preparation for Use as a Protein Precipitant.
US2108553A (en) Method for making lead arsenate in finely divided form
Ricci et al. The System Magnesium Molybdate-Water and the 25 Isotherm of the System MgMoO4-MgCl2-H2O
Thorpe et al. LXXXI.—On phosphorus tetroxide